Drugs & Targets Lynparza receives positive EU CHMP opinion in breast cancer March 08, 2019Vol.45 No.10
Drugs & Targets FDA approves Keytruda for adjuvant treatment of melanoma February 22, 2019Vol.45 No.08
Drugs & Targets FDA accepts IND for TR1801-ADC, an ADC targeting cMet positive solid tumors February 22, 2019Vol.45 No.08
Drugs & Targets FDA grants priority review to Merck’s sBLA for Keytruda monotherapy in SCLC February 22, 2019Vol.45 No.08
Drugs & Targets FDA publishes revised draft guidance for investigational tobacco products February 22, 2019Vol.45 No.08
